-
Je něco špatně v tomto záznamu ?
Rate Control by Transoesophageal Atrial Overdrive Pacing for Refractory Supraventricular Tachycardia with Severe Ventricular Dysfunction: A Bridge to Recovery
C. Paech, J. Janousek, F. Wagner, RA. Gebauer,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
- MeSH
- elektrokardiografie MeSH
- kardiomyopatie komplikace MeSH
- kardiostimulace umělá škodlivé účinky metody MeSH
- kojenec MeSH
- komorová dysfunkce komplikace MeSH
- lidé MeSH
- novorozenec MeSH
- srdeční frekvence * MeSH
- supraventrikulární tachykardie terapie MeSH
- Check Tag
- kojenec MeSH
- lidé MeSH
- mužské pohlaví MeSH
- novorozenec MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Tachyarrhythmia-induced cardiomyopathy (TIC) is a rare, yet life-threatening phenomenon in children. TIC has been defined as myocardial dysfunction that is entirely or partially reversible after control of the responsible tachyarrhythmia and is typically caused by an incessant supraventricular tachycardia. In cases of unsuccessful termination of the tachycardia, cardiogenic shock may occur. Several authors favour the use of mechanical circulatory support in such cases. Particularly with regard to these partly severe cases, the authors would like to present the option of transoesophageal overdrive pacing (TOP) as a tool for initial heart rate control and hemodynamic stabilization of patients with TIC refractory to conventional strategies of tachycardia termination. Chart review for patients receiving TOP during the last 5 years in two centres was performed. A case series of successful TOP including technique and outcomes is depicted. Rate control through TOP is a safe and effective option to restore acceptable hemodynamics in infants with refractory supraventricular tachycardia and severe impairment of ventricular function. It presents the possibility of immediate heart rate control and offers time for myocardial recovery and safe implementation of antiarrhythmic drug therapy.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17013409
- 003
- CZ-PrNML
- 005
- 20170427101347.0
- 007
- ta
- 008
- 170413s2017 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00246-016-1503-7 $2 doi
- 035 __
- $a (PubMed)27837305
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Paech, C $u Department for Pediatric Cardiology, University of Leipzig - HELIOS Heart Center, Strümpellstr. 39, 04289, Leipzig, Germany. christian.paech@med.uni-leipzig.de.
- 245 10
- $a Rate Control by Transoesophageal Atrial Overdrive Pacing for Refractory Supraventricular Tachycardia with Severe Ventricular Dysfunction: A Bridge to Recovery / $c C. Paech, J. Janousek, F. Wagner, RA. Gebauer,
- 520 9_
- $a Tachyarrhythmia-induced cardiomyopathy (TIC) is a rare, yet life-threatening phenomenon in children. TIC has been defined as myocardial dysfunction that is entirely or partially reversible after control of the responsible tachyarrhythmia and is typically caused by an incessant supraventricular tachycardia. In cases of unsuccessful termination of the tachycardia, cardiogenic shock may occur. Several authors favour the use of mechanical circulatory support in such cases. Particularly with regard to these partly severe cases, the authors would like to present the option of transoesophageal overdrive pacing (TOP) as a tool for initial heart rate control and hemodynamic stabilization of patients with TIC refractory to conventional strategies of tachycardia termination. Chart review for patients receiving TOP during the last 5 years in two centres was performed. A case series of successful TOP including technique and outcomes is depicted. Rate control through TOP is a safe and effective option to restore acceptable hemodynamics in infants with refractory supraventricular tachycardia and severe impairment of ventricular function. It presents the possibility of immediate heart rate control and offers time for myocardial recovery and safe implementation of antiarrhythmic drug therapy.
- 650 _2
- $a kardiostimulace umělá $x škodlivé účinky $x metody $7 D002304
- 650 _2
- $a kardiomyopatie $x komplikace $7 D009202
- 650 _2
- $a elektrokardiografie $7 D004562
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a srdeční frekvence $7 D006339
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a novorozenec $7 D007231
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a supraventrikulární tachykardie $x terapie $7 D013617
- 650 _2
- $a komorová dysfunkce $x komplikace $7 D018754
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Janousek, J $u Children's Heart Centre, 2nd Medical Faculty of Medicine, Charles University in Prague and Motol University Hospital, V úvalu 84, 150 06, Prague, Czech Republic.
- 700 1_
- $a Wagner, F $u Department for Pediatric Cardiology, University of Leipzig - HELIOS Heart Center, Strümpellstr. 39, 04289, Leipzig, Germany.
- 700 1_
- $a Gebauer, R A $u Department for Pediatric Cardiology, University of Leipzig - HELIOS Heart Center, Strümpellstr. 39, 04289, Leipzig, Germany.
- 773 0_
- $w MED00003725 $t Pediatric cardiology $x 1432-1971 $g Roč. 38, č. 2 (2017), s. 228-233
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27837305 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20170427101707 $b ABA008
- 999 __
- $a ok $b bmc $g 1199874 $s 974187
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 38 $c 2 $d 228-233 $e 20161111 $i 1432-1971 $m Pediatric cardiology $n Pediatr Cardiol $x MED00003725
- LZP __
- $a Pubmed-20170413